Employer record no. 19088
ReCode Therapeutics, Inc.
US DOL LCA disclosure data, FY2021 to FY2025
Total LCA filings
16
Certified
13
Denied
0
FY2025 filings
3
Filings by fiscal year
Peer rank
#1,701 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2021 | 2 | 2 | 0 | $136,500 | $115,190 |
| FY2022 | 2 | 2 | 0 | $98,000 | $86,351 |
| FY2023 | 6 | 6 | 0 | $123,260 | $114,691 |
| FY2024 | 3 | 2 | 0 | $117,136 | $113,270 |
| FY2025 | 3 | 1 | 0 | $109,419 | $104,132 |
What they file for
- scientist ii$136,6673
- research associate ii$74,0002
- senior research associate i$76,0002
- senior research associate i, gene editing$115,0002
- aerosol scientist ii$120,0001
- director of formulation development$215,0001
- research associate ii, bioanalytical$88,0001
- research associate, aerosol - lipid nano particle$79,5601
Where
- menlo park, ca13
- dallas, tx3
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for ReCode Therapeutics, Inc. and any other employer they watch.
Certification rate 81.3%How these numbers are computed